MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2023 International Congress

August 27-31, 2023. Copenhagen, Denmark.

View by Title View Categories
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z
  • Factors affecting adaptive deep brain stimulation (aDBS) indications in Parkinson’s disease

    J. Tanimura (Matsumoto, Japan)

  • Factors influencing health-related quality of life of patients with spinocerebellar ataxia

    N. Weber, M. Buchholz, A. Rädke, J. Faber, T. Schmitz-Hübsch, H. Jacobi, T. Klockgether, B. Michalowsky (Greifswald, Germany)

  • Factors influencing voice function after deep brain stimulation in Parkinson’s disease

    H. Jergas, T. Tsuboi, V. Stopic, D. Nakatsubo, C. Hennen, S. Maesawa, J. Einhaus, R. Saito, V. Visser-Vandewalle, M. Katsuno, M. Barbe (Cologne, Germany)

  • Failure of model-based outcome monitoring in Parkinson’s Disease Apathy

    W. Gilmour, G. Mackenzie, M. Feile, A. Macleod, V. Marshall, D. Steele, T. Gilbertson (Dundee, United Kingdom)

  • Falls in Mild Cognitive Impairment with Lewy bodies (MCI-LB).

    E. Lirani Silva, S. Waite, C. Hamilton, P. Donaghy, J. O'Brien, J. Taylor, J. Lloyd, L. Allan, M. Firbank, A. Thomas, A. Yarnall (Newcastle, United Kingdom)

  • Familial Parkinson’s: Epidemiological data at Blida University Hospital.

    M. Benmahdjoub, K. Kesraoui, S. Bouchetara, M. Arezki (Blida, Algeria)

  • Feasibility and acceptability of implementing dignity therapy as a supportive intervention for people with movement disorders.

    D. Labuschagne, J. Fleisher, K. Woo, G. Fitchett (Chicago, USA)

  • Feasibility and efficacy of a multidisciplinary telemedicine intervention program to reduce falls and gait impairment in Parkinson’s disease (NCT04694443).

    A. Garcia-Bustillo, FV. Valiñas Sieiro, A. Olivares, M. Jahouh, J. Gonzalez-Santos, M. Allende, JJ. Gonzalez-Bernal, A. Arnaiz-Gonzalez, J. Diez-Pastor, J. Trejo, JL. Garrido-Labrador, E. Cubo (Burgos, Spain)

  • Feasibility, Reliability and Value of Remote Levodopa Challenge Test in Parkinson’s Disease

    Z. Zeng, W. Shi, X. Wan, Z. Lin, Z. Chen, C. Zhang (Shanghai, China)

  • Fecal tyrosine decarboxylase and motor response complications in Parkinson’s Disease

    JW. Hor, SY. Lim, TS. Toh, CW. Chong, CSJ. Teh, SL. Song, KY. Khaw, AH. Tan (Kuala Lumpur, Malaysia)

  • « Previous Page
  • 1
  • …
  • 74
  • 75
  • 76
  • 77
  • 78
  • …
  • 186
  • Next Page »
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Yerba Mate (Ilex paraguaiensis) protects dopaminergic neurons degeneration and improve their maturation in culture
  • #26133 (not found)
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley